Jonathan Evrard
8PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 09, 2022
Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban-treated patients and healthy controls.Jonathan Evrard, Romain Siriez, Céline Bouvy
|Oct 06, 2021
Simultaneous assessment of DOACs effect on clot formation and fibrinolysis with the FibWave.Jonathan Evrard, Vincent Maloteau, Jean-Michel Dogné
|May 20, 2021
Comparison is not reason: Pitfalls in reporting thrombin generation results in anticoagulated patients.Jonathan Douxfils, Jonathan Evrard, Michaël Hardy
|Dec 14, 2020
Assessment of acquired activated protein C resistance with the FibWave and comparison with the ETP-based APC resistance.Jonathan Evrard, Laure Morimont, Marie Didembourg
|Oct 10, 2020
Are the DOAC plasma level thresholds appropriate for clinical decision-making? A reappraisal using thrombin generation testing.Jonathan Evrard, Michaël Hardy, Jean-Michel Dogné
|May 20, 2020
Evaluation of a new thromboplastin reagent STA-NeoPTimal on a STA R Max analyzer for the measurement of prothrombin time, international normalized ratio and extrinsic factor levels.François Mullier, Marie-Sophie Paridaens, Jonathan Evrard
Pageof 2
